A recent study tested a new digital therapeutic for effectiveness on both substance abuse and depression. <\/p>\n
In 2018 more than 20 million Americans met criteria for substance use disorder, particularly alcohol abuse (73%). During the COVID-19 pandemic, alcohol sales have risen sharply, up 54% from the previous year.<\/p>\n
In this Mental Health Minute, Judith J. Prochaska, PhD, MPH points out that the pandemic has made it difficult for patients to seek traditional forms of counseling. She discusses a digital therapeutic that can be an adjunct for traditional therapies, and results from the latest study on the treatments efficacy for substance abuse and mood disorders.<\/p>\n
Dr Prochaska is a professor in the department of medicine at Stanford University with the Stanford Prevention Research Center and a member of the Stanford Cancer Institute.<\/p>\n
Would you recommend a digital therapeutic to your patients? Share comments with your colleagues by emailing PTEditor@mmhgroup.com<\/a>. Comments may be shared online pending review and editing for style.<\/p>\n <\/p>\n Read the rest here: <\/p>\n Could Artificial Intelligence Improve Cognitive Behavioral Therapy? - Psychiatric Times<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" A recent study tested a new digital therapeutic for effectiveness on both substance abuse and depression. In 2018 more than 20 million Americans met criteria for substance use disorder, particularly alcohol abuse (73%) Continue reading